EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
-5.42%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$319M
AUM Growth
+$319M
(-8.8%)
Cap. Flow
+$2.02M
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
63.37%
Holding
71
New
10
Increased
20
Reduced
18
Closed
16
Top Buys
| 1 |
The Ensign Group
ENSG
|
$13.3M |
| 2 |
GSK
GSK
|
$12.5M |
| 3 |
Ascendis Pharma
ASND
|
$9.63M |
| 4 |
Envista
NVST
|
$8.87M |
| 5 |
DexCom
DXCM
|
$6.65M |
Top Sells
| 1 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$17.6M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$9.61M |
| 3 |
RDUS
Radius Health, Inc.
RDUS
|
$9.42M |
| 4 |
eHealth
EHTH
|
$9.09M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
$5.37M |
Sector Composition
| 1 | Healthcare | 87.73% |
| 2 | Real Estate | 4.64% |
| 3 | Industrials | 2.03% |
| 4 | Communication Services | 1.05% |
| 5 | Financials | 0.89% |
